Adage Capital Partners Gp, L.L.C. 10x Genomics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $8.07 Million - $13.5 Million	-235,116 Reduced 61.05%	150,000 $8.39 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $9.1 Million - $10.5 Million	-178,509 Reduced 31.67%	385,116 $21.5 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $2.46 Million - $3.88 Million	69,509 Added 14.07%	563,625 $31.4 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $12.1 Million - $20.4 Million	494,116 New	494,116 $18 Million
Q4 2019 Feb 14, 2020	SELL	$46.07 - $79.54 $6.91 Million - $11.9 Million	-150,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $7.5 Million - $9.3 Million	150,000 New	150,000 $7.56 Million

286

95.8M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.